CP
NUS icon

Castleview Partners’s Nu Skin NUS Stock Holding History

Castleview Partners’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$14K Buy
+255
New +$14.5K 0.01% 619

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Castleview Partners's NUS Position: Q2 2021 in Review

Castleview Partners opened a new position in Nu Skin (NUS) in Q2 2021: 255 shares worth $14K. The stake represents 0.01% of the portfolio and ranks #619 among its holdings.

273 funds tracked by Wall St. Rank hold NUS as of Q2 2021.

  • Castleview Partners held 255 shares of Nu Skin worth $14K as of Q2 2021.
  • Nu Skin was a new Castleview Partners position in Q2 2021.
  • Nu Skin made up 0.01% of Castleview Partners's portfolio in Q2 2021, its #619 holding.
  • 273 funds tracked by Wall St. Rank held Nu Skin as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.